LF
LiftPoint Family Wealth Advisors LLC
13F filer · CIK 0002110810Reported Aug 5, 2026
Net buyer this quarter
13F portfolio value$148MU.S. long equity reported on 13F
Positions3512 new · 1 closed
Net flow last quarter+$6.82MBuys minus sells
Top 10 positions weight12.5%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 5, 202635 positions | |||||
| $4.88M | 3.31% | 1.43% | -16.2% | Q4 2025 | |
| $3.93M | 2.66% | 0.00% | +21.1% | Q4 2025 | |
| $2.03M | 1.37% | 0.00% | +58.2% | Q4 2025 | |
| $1.8M | 1.22% | 0.00% | +1.5% | Q4 2025 | |
| $1.6M | 1.08% | 0.00% | +18.5% | Q4 2025 | |
| $1.17M | 0.79% | 0.00% | +57.2% | Q4 2025 | |
| $988K | 0.67% | 0.00% | +13.6% | Q4 2025 | |
| $718K | 0.49% | 0.00% | +93.9% | Q4 2025 | |
| $691K | 0.47% | Not reported | -2.3% | Q4 2025 | |
| $687K | 0.47% | 0.00% | +93.8% | Q4 2025 | |
| $677K | 0.46% | 0.00% | +106.5% | Q4 2025 | |
| $643K | 0.44% | Not reported | Not reported | Q1 2026 | |
| $615K | 0.42% | 0.00% | +77.3% | Q4 2025 | |
| $606K | 0.41% | 0.00% | New | Q2 2026 | |
| $536K | 0.36% | 0.00% | +11.6% | Q4 2025 | |
| $518K | 0.35% | 0.00% | +57.8% | Q4 2025 | |
| $510K | 0.35% | Not reported | +71.1% | Q4 2025 | |
| $479K | 0.32% | 0.00% | -1.6% | Q4 2025 | |
| $425K | 0.29% | 0.00% | New | Q2 2026 | |
| $398K | 0.27% | 0.00% | Not reported | Q4 2025 | |
| $386K | 0.26% | Not reported | +89.2% | Q4 2025 | |
| $364K | 0.25% | 0.00% | +58.6% | Q4 2025 | |
| $299K | 0.20% | Not reported | New | Q2 2026 | |
| PBPMBSPuramed Bioscience Inc. | $294K | 0.20% | 0.00% | +8.3% | Q4 2025 |
| $268K | 0.18% | 0.00% | -7.6% | Q4 2025 | |
| $257K | 0.17% | 0.00% | +13.0% | Q4 2025 | |
| $255K | 0.17% | 0.00% | New | Q2 2026 | |
| $253K | 0.17% | 0.00% | New | Q2 2026 | |
| $248K | 0.17% | 0.00% | New | Q2 2026 | |
| $247K | 0.17% | 0.00% | +11.7% | Q4 2025 | |
| $240K | 0.16% | 0.00% | New | Q2 2026 | |
| $237K | 0.16% | 0.00% | New | Q2 2026 | |
| $230K | 0.16% | 0.00% | New | Q2 2026 | |
| $205K | 0.14% | 0.00% | Not reported | Q4 2025 | |
| $204K | 0.14% | 0.00% | New | Q2 2026 | |
| Q1 2026Reported Apr 29, 202624 positions | |||||
| $4.89M | 4.05% | 1.71% | +7.7% | Q4 2025 | |
| $2.84M | 2.35% | 0.00% | +3.7% | Q4 2025 | |
| $2.2M | 1.82% | 0.00% | -6.5% | Q4 2025 | |
| $1.12M | 0.92% | 0.00% | +21.0% | Q4 2025 | |
| $1.04M | 0.86% | 0.00% | +0.3% | Q4 2025 | |
| $955K | 0.79% | 0.00% | -1.9% | Q4 2025 | |
| $738K | 0.61% | 0.00% | +10.3% | Q4 2025 | |
| $602K | 0.50% | Not reported | New | Q1 2026 | |
| $568K | 0.47% | 0.00% | -58.8% | Q4 2025 | |
| $544K | 0.45% | Not reported | -28.6% | Q4 2025 | |
| $415K | 0.34% | 0.00% | -7.1% | Q4 2025 | |
| $409K | 0.34% | 0.00% | -6.2% | Q4 2025 | |
| $333K | 0.28% | 0.00% | +4.7% | Q4 2025 | |
| $286K | 0.24% | 0.00% | +3.5% | Q4 2025 | |
| $285K | 0.24% | 0.00% | +14.6% | Q4 2025 | |
| $284K | 0.24% | 0.00% | +17.2% | Q4 2025 | |
| $277K | 0.23% | 0.00% | -6.1% | Q4 2025 | |
| PBPMBSPuramed Bioscience Inc. | $273K | 0.23% | 0.00% | -1.1% | Q4 2025 |
| $249K | 0.21% | 0.00% | -0.1% | Q4 2025 | |
| $242K | 0.20% | Not reported | -2.5% | Q4 2025 | |
| $219K | 0.18% | 0.00% | +3.1% | Q4 2025 | |
| $210K | 0.17% | 0.00% | New | Q1 2026 | |
| $207K | 0.17% | Not reported | -10.2% | Q4 2025 | |
| $203K | 0.17% | 0.00% | +10.8% | Q4 2025 | |
| Q4 2025Reported Feb 13, 202626 positions | |||||
| $4.83M | 4.13% | 1.59% | New | Q4 2025 | |
| $2.93M | 2.50% | 0.00% | New | Q4 2025 | |
| $1.67M | 1.42% | 0.00% | New | Q4 2025 | |
| $1.27M | 1.08% | 0.00% | New | Q4 2025 | |
| $1.21M | 1.03% | 0.00% | New | Q4 2025 | |
| $986K | 0.84% | 0.00% | New | Q4 2025 | |
| $874K | 0.75% | 0.00% | New | Q4 2025 | |
| $872K | 0.74% | 0.00% | New | Q4 2025 | |
| $704K | 0.60% | Not reported | New | Q4 2025 | |
| $469K | 0.40% | 0.00% | New | Q4 2025 | |
| $376K | 0.32% | 0.00% | New | Q4 2025 | |
| $348K | 0.30% | 0.00% | New | Q4 2025 | |
| $342K | 0.29% | 0.00% | New | Q4 2025 | |
| $321K | 0.27% | 0.00% | New | Q4 2025 | |
| $315K | 0.27% | 0.00% | New | Q4 2025 | |
| $307K | 0.26% | 0.00% | New | Q4 2025 | |
| PBPMBSPuramed Bioscience Inc. | $276K | 0.24% | 0.00% | New | Q4 2025 |
| $271K | 0.23% | Not reported | New | Q4 2025 | |
| $271K | 0.23% | 0.00% | New | Q4 2025 | |
| $271K | 0.23% | 0.00% | New | Q4 2025 | |
| $266K | 0.23% | Not reported | New | Q4 2025 | |
| $260K | 0.22% | 0.00% | New | Q4 2025 | |
| $249K | 0.21% | 0.00% | New | Q4 2025 | |
| $245K | 0.21% | 0.00% | New | Q4 2025 | |
| $230K | 0.20% | 0.00% | New | Q4 2025 | |
| $222K | 0.19% | 0.00% | New | Q4 2025 | |
Premium opens every quarter this fund has filed